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Background: In this study, we sought to analyze our experience in urgent surgical management for embolized
cardiac septal and ductal occluder devices resulting from trans-catheter closure of atrial septal defect, ventricular
septal defect and patent ductus arteriosus in childhood patient group.
Methods: We retrospectively reviewed 9 patients (aged 2–15 years) who underwent urgent surgery due to cardiac
septal and ductal occluder embolization between January 2007 and December 2010. Congenital defects were atrial
septal defect (n = 6), ventricular septal defect (n = 1), and patent ductus arteriosus (n = 2). Risk factors for device
embolization and urgent surgical management techniques for embolized device removal were discussed.
Results: Removal of embolized devices in all cases and repair of damaged tricuspid valve in 2 patients were
performed. Inevitably, all congenital defects were closed or ligated up to the primary defect. Total circulator arrest
necessitated in 1 patient with ascending aortic device embolization. All operations were completed successfully and
no hospital mortality or morbidity was encountered.
Conclusions: Although closure of left to right shunting defects by percutaneous occluder devices has a lot of
advantages, device embolization is still a major complication. If embolized device retrieval fails with percutaneous
intervention attempts, surgical management is the only method to remove embolized devices. In this circumstance,
to provide an uneventful perioperative course, urgent management strategies should be well planned.
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Congenital heart diseases such as atrial septal defect
(ASD), ventricular septal defect (VSD) and patent ductus
arteriosus (PDA) are common type of childhood cardiac
defects with an incidence of approximately 1 in 100 live
births [1]. Surgical repair of all these defects was method
of choice, until King et al. performed the first trans-
catheter closure of ASD [2]. Reported series with percu-
taneous deployment of occluder devices emphasize that
trans-catheter closure technique avoids open-heart sur-
gery and its associated complications. However, these
interventional procedures are accompanied with their* Correspondence: cerrah06@yahoo.com
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reproduction in any medium, provided the orown major complications such as device embolization.
In surgical literature, management of embolized devices
was discussed in case reports and recently a multicenter
experience was reported [3]. There is still lack of surgical
management strategies for embolized devices in child-
hood and in this study we aimed to share our
experiences.Methods
The study was approved by the ethics committee of our
institution, and because of its retrospective nature, pa-
tient consent was waived. This study is a review of 9
childhood patients who were urgently operated due to
embolized cardiac septal and ductal occluder devices be-
tween January 2007 and December 2010 in our clinic.
Preoperative and perioperative records of urgentlyal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Embolised AmplatzerW ductal occluder in ascending
aorta.
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defined with a number. Adult patients, patients with late
device complications and uneventfully retrieved devices
by percutaneous interventions were excluded.
Statistical analysis
Data are expressed as absolute values, percentages, or
mean ± SD where appropriate.
Results
Between January 2007 and December 2010, 656 child-
hood patients (265 with ASD, 354 with PDA and 37 with
VSD) underwent percutaneous closure of their defect at
our institution. Device embolization requiring urgent
surgical management occurred in 9 patients with a rate
of 2.2%, 1.7% and 0.5% for ASD, VSD and PDA,
respectively. Mean age was 8.8 ± 4.3 years, and six of
9 patients were female (66.6%).Figure 2 Echocardiographic and surgical views of embolised Amplatz
leaflet chordas. Please note the ruptured chorda on the device which occuMajority of the primary defects were ASD (6 patients)
with a diameter equal or grater than 10 mm and closure
device waist sizes were ranging 19-28mm. Mean left
to right shunt ratio (Qp/Qs) in patients with ASD was
4.9 ± 3.3 (range, 1.5-11) and rim tissue around the
defects was ≥ 5 mm in echocardiography before trans-
catheter closure . However, aortic rim in two patients
and inferior caval rim in one patient were found to be
just a thin membrane in intraoperative examination. In
another patient (patient number #5) who was reported
to have two ASDs in echocardiography, a large single
ASD divided transversely with a thin band was observed
intraoperatively. In remaining two patients with ASD,
device embolization was due to the learning curve of
the operator.
Defects were PDA in 2 patients. Systolic gradient
between aorta and pulmonary artery over PDA was
8 mmHg in patient #7 which was found low because of
the concomitant ASD and 112 mmHg in patient #8 with
solely PDA. Thus, the occluder device was embolized
and stuck in ascending aorta in patient #7 during inter-
ventional procedure (Figure 1). Pulmonary artery
embolization occurred in patient #8 just after implant-
ation of the device and it was tangled with tricuspid
valve during percutaneous retrieval (Figure 2). In patient
#9 with VSD, systolic gradient between right and left
ventricle was 61 mmHg. The occluder device was
tangled with chordae tendineae of tricuspid valve while
delivering it (Figure 3).
Timing of events, embolization sites, embolized
devices and their sizes are presented for each case in
Table 1. Surgery decisions were made after failure of per-
cutaneous attempts to retrieve embolized devices. Al-
though all patients were heparinized during catheter
intervention, six patients were additionally heparinized
with 100U/kg heparin because activated coagulation
time (ACT) was under 180 seconds, in order to prevent
clot formation over device during surgical preparation
and transfer to the operation room. Transesophageal
echocardiography (TEE) was performed in all patientserW ductal occluder. Device was tangled with tricuspid valve anterior
rred during percutaneous retrieval attempts.
Figure 3 Embolised AmplatzerW septal occluder tangled with
tricuspid valve and chordas.
Figure 4 Embolised AmplatzerW septal occluder stuck in the
annulus of the pulmonary valve.
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through median sternotomy. Aortic cannulation, select-
ive vena cava superior and vena cava inferior cannula-
tions were achieved. PDA was ligated in two patients
just prior to initiation of cardiopulmonary bypass (CPB).
An aortic cross-clamp (CC) was applied and antegrade
cold cardioplegia was administered into the aortic root
to achieve prompt diastolic cardiac arrest, except one
patient with ascending aortic device embolization. Snar-
ing of both vena cava superior and inferior, right atriot-
omy was performed. All embolized devices were easily
removed directly or by folding two opposite edges of the
device via forceps even it was stuck in the annulus of
the valves or fell into the left ventricle (Figure 4). Fol-
lowing removal of embolized devices, tricuspid septal
leaflet chordae damaged in 2 patients reattached to the
septal leaflet and commissure damaged in one patient
was repaired with prolene suture. According to the size
of the defects, ASD and VSD closures were performed
directly or using a pericardial patch manner.
In patient with ascendant aortic embolization (patient
#7 with PDA and concomitant ASD), device position
was confirmed with TEE following initiation of CPB and













1 4 ASD 0.66 20 6.08
2 8 ASD 0.84 19 5
3 9 ASD 0.9 22 11
4 15 ASD 1.26 27 3.5
5 15 ASD 1.57 27-28 4
6 9 ASD 1.08 10 1.5
7 8 PDA 0.81 4.5 1.4
8 2 PDA 0.45 4.55 3.1
9 10 mVSD 0.79 7 2.2
ASD: Atrial septal defect, mVSD: Muscular ventricular septal defect, PDA: Patent ducascending aortotomy was performed just left lateral side
of the aortic cannula via total circulator arrest (TCA) of
6 minutes. Embolized device was removed and aortot-
omy was closed in two layers. While heating the patient,
direct closure of additional secundum ASD was per-
formed through the right atriotomy. In early post-
operative echocardiography, systolic pulmonary artery
pressure was shown decreased from 82 to 45 mmHg.
Surgical management data are presented for each patient
in Table 2.
The mean time interval between decision of the surgi-
cal removal of the embolised device and surgical treat-
ment was 65 ± 16.5 (range, 40–90) minutes. Mean blood
transfusion was 1.88 ± 0.64 units. Mean duration of in-
tensive care unite stay was 1.2 ± 0.44 days and mean
total hospital stay was 4.9 ± 1.3 days. Any tromboembo-
lism or peripheral artery complication including ische-
mia was not observed postoperatively. No mortality or
surgical complication was encountered during hospital
stay. The mean follow-up period was 37.8 ± 17.1






AmplatzerW 9-PFO-024(38–34) Tricuspid valve 1 day
AmplatzerW 9-PFO-022(32–36) Right ventricle 1 day
AmplatzerW 9-PFO-026(36–40) Left ventricle Peroperative
AmplatzerW 9-PFO-019(29–33) Pulmonary valve 1 day
AmplatzerW 9-PFO-028(38–42) Right atrium Peroperative
Biostar BSR-28 Tricuspid valve 2 days
AmplatzerW 9-PDA006(10–8) Ascending Aorta Peroperative
AmplatzerW Nit.Ocluder(9–6) Tricuspid valve Peroperative
AmplatzerW 9-VSDmusc-008(16) Tricuspid Valve Peroperative
tus arteriosus, Qp/Qs: Left to right shunt ratio.







TCA CC CPB Surgical management
(Minute) (Minute) (Minute)
1 4 ASD - 28 44 ASO removal and ASD pr.
2 8 ASD - 37 45 ASO removal and ASD rpp.
3 9 ASD - 18 30 ASO removal and ASD pr.
4 15 ASD - 30 45 ASO removal and ASD rpp.
5 15 ASD - 28 37 ASO removal and ASD rpp.
6 9 ASD - 33 42 ASO removal, Tricuspid valve septal leaflet chorda and posterior leaflet septal
commissure repair, ASD rpp
7 8 PDA 6 0 116 PDA ligation, Coil removal via aortotomy with TCA and ASD pr.
8 2 PDA - 30 42 PDA ligation, Tricuspid valve septal leaflet corda repair





ASD: Atrial septal defect, ASO: Atrial septal occluder, CC: Cross clamp time, CPB: Total cardiopulmonary bypass time, mVSD: Muscular ventricular septal defect, PDA:
Patent ductus arteriosus, pr: Primer repair, Qp/Qs: Mean left to right shunt ratio, rpp: repair with pericardial patch, TCA: Total circulatory arrest time, VSO: Ventricle
septal occluder.
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follow-up. In two patients with tricuspid valve repair,
mild regurgitation was reported in their last follow up
echocardiography.
Discussion
Interventional trans-catheter closure for all types of car-
diac defects with left to right shunting gained wide
popularity and became a standard technique against sur-
gery for nearly two decades all over the world. Recent
studies including both adult and childhood patients
emphasizes that trans-catheter closure is a safe method
with shorter hospital stay, less mortality and morbidity
rates. Moreover, it also obviates surgical risk factors and
inevitable operation scar of surgery [4-7]. However, this
procedure is not free of complications. Embolization of
the device may occur in unexpected sites of circulatory
system and may cause serious damages. In the literature,
embolization rates were reported 4% in 1991 [8], 20% in
1996 [9], and dramatically decreased to 0.55% in 2005
with new generation devices [10]. In a review reported
in 1996, suggested mechanisms for acute failure were
operator related factors resulting from inadequate ex-
perience (learning curve), inaccurate deployment, inad-
equate defect rim to hold the device, tearing of the
interatrial septum especially at the lower rim of the ASD
owing to catheter and device manipulations and Sideris
buttoned device itself [11]. Berdat et al. reviewed their
surgical experiences with embolized Sideris and ASDOS
devices and suggested that new generation AmplatzerW
devices indicated more promising results [12]. Despite
new generation occluder devices were developed, embo-
lized devices which require surgical management are still
reported and majority of these are case reports [13-15].
In a recent multi-center study which investigates deviceembolization complications, 3 patients died of stroke
due to cerebral embolism and cardiac perforation was
noted in one patient. The authors concluded that ‘Once
a complication leading to surgery occurs, mortality is
significantly greater than that of primary surgical ASD
closure’ [3].
In our study majority of primary defects were ASD
and embolization rate was 2.2%. Patient selection for
ASD closure with occluder device is generally performed
according to the sizes of the defect and rim. Misra et al.
reported their experience with defective aortic rim which
caused device embolization to pulmonary artery and
they emphasized the importance of the aortic rim in de-
vice deployement [16]. If rim thickness is weak or just a
membrane, this may lead device embolization. In our
study, aortic rim in two patients and inferior cava rim in
one patient were a thin membrane. Additionally, in pa-
tient # 5 who was thought to have two ASDs in echocar-
diography, intraoperative investigation revealed that
there existed actually one large ASD divided by a thin
band. Combination of thin rim and high Qp/Qs might
have been responsible for the embolization in these
patients. Moreover, during the percutaneous retrieval
attempts, intracardiac structure damage may occur par-
ticularly at valvular and subvalvular apparatus. Within
our experience, tricuspid septal leaflet chordae injury in
two cases and posterior leaflet septal commissure dam-
age in one case were encountered during operations.
These injuries were repaired successfully.
Device embolization rate during trans-catheter PDA
occlusion was reported as 0.5% in a multi-center study
[17]. Successful surgical removal of embolized PDA
devices from pulmonary arteries and descending aorta
were reported formerly [13,14]. Magee et al. suggests
that embolization of the PDA device more commonly
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circulation because of the pressure gradient [18]. We
encountered with embolized PDA devices in two
cases (patient #7 and #8). PDA diameters were 4.5 and
4.55 mm. Although ductal diameters were small, gradi-
ents between aorta and pulmonary artery were the rea-
son for the device embolization. In patient #7 with
concomitant ASD, PDA occluder device dislodged and
migrated to ascending aorta due to high pulmonary
pressure. In patient #8, gradient was 112 mmHg and
device was embolized to pulmonary artery. Although
PDA diameters were similar, the gradient in these cases
determined the dislodgement of the device and the
embolization site.
Holzer et al. reported device embolization rate of
2.7% in muscular VSD closure in both adult and child-
hood patients [19]. In 2007, device embolization rate
was reported as 0.9% for the European registry of
AmplatzerW VSD occluder [6]. In a review reported in
2010, the author emphasizes TEE guidance in trans-
catheter device closure of muscular VSD [20]. In our data,
device embolization occurred in one patient (patient #9)Figure 5 A possible algorithm for surgical management of complicatewith muscular VSD. Device was tangled with tricuspid
valve chordae during deployment probably because of the
lack of TEE guidance.
Device removal was performed through the right
atrium in our 8/9 patients. Performing right atriotomy
provided us a good surgical exposure to reach all intra-
cardiac structures even to the left ventricle via ASD.
Devices even stuck to the valvular annulus were
removed easily via folding their edges with forceps.
Intracardiac structure damages which possibly occurred
due to percutaneous device retrieving attempts at valvu-
lar and subvalvular apparatus were repaired successfully.
Only one of the devices which was embolized to the
ascending aorta was removed via TCA after confirm-
ing its position with TEE. Perioperative TEE guidance
is essential particularly in these patients, because the de-
vice migration might occur after aortic cannulation and
initiation of CPB [15].
In post operative period, fortunately we did not en-
counter any embolism, tamponade or arrhythmias. The
reasons for no death or uneventful course in our opera-
tions may be related to stand-by cardiac surgical team,d embolized devices.
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of embolization, appropriate surgical management strat-
egy. An algorithm may be suggested considering our
limited experiences together with the results of the lit-
erature for a more helpful surgical management strategy.
A possible algorithm is indicated in Figure 5.
Conclusions
Occluding of left to right shunting defects by devices is
less invasive than surgery. Echocardiographic evaluation
of rim quality and measurement of the gradients may
help choose the appropriate patients for interventional
procedures. During the intervention, TEE guidance is
needed to confirm the echocardiographic findings and
support the deployment procedures. Despite all,
embolization is still a major complication in interven-
tional closure of the defects. If percutaneous catheter re-
trieval attempts fail, surgical management is the only
method to remove the embolized devices. However, an
urgent surgery in a patient who already had many hours
of anesthesia perhaps with compromised hemodynamics
due to blood loss and/or damaged intra cardiac struc-
tures is supposed to have more intraoperative or post-
operative complications than an elective surgical repair
of the primary lesion. Our experiences without any ser-
ious complication may be attributed to the appropriate
surgical management strategy.
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